Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (201-210 of 655) with videos related to

Pageof 66
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancerC J Rodenburg, K Nooter, H Herweijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Carcinoma of unknown primary: identification of a treatable subset?A van der Gaast, J Verweij, S C Henzen-Logmans, et al.
Journal of Clinical Microbiology|January 24, 2014
Evaluation of four single-locus markers for Leishmania species discrimination by sequencingGert Van der Auwera, Christophe Ravel, Jaco J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNUJ H Schornagel, J Verweij, P H de Mulder, et al.
International Journal of Cancer|December 22, 1999
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEPR de Wit, M Louwerens, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)P H Hilkens, J Verweij, C J Vecht, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholineL C Pronk, A S Planting, R Oosterom, et al.
British Journal of Cancer|November 21, 1998
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patientsR de Wit, W H Kruit, G Stoter, et al.
Emerging Infectious Diseases|October 19, 2005
Cyclosporiasis outbreak, IndonesiaMarjolijn C A Blans, Ben U Ridwan, Jaco J Verweij, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 4, 1994
[Strongyloides infections in former prisoners of war in South-East Asia in the second World War; additional information from serological diagnosis]A M Polderman, J J Verweij, J C Vetter, et al.
Pageof 66

Showing results (201-210 of 655) with videos related to

Sort By:
Pageof 66
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1991
Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancerC J Rodenburg, K Nooter, H Herweijer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1990
Carcinoma of unknown primary: identification of a treatable subset?A van der Gaast, J Verweij, S C Henzen-Logmans, et al.
Journal of Clinical Microbiology|January 24, 2014
Evaluation of four single-locus markers for Leishmania species discrimination by sequencingGert Van der Auwera, Christophe Ravel, Jaco J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNUJ H Schornagel, J Verweij, P H de Mulder, et al.
International Journal of Cancer|December 22, 1999
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEPR de Wit, M Louwerens, P H de Mulder, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1997
Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)P H Hilkens, J Verweij, C J Vecht, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholineL C Pronk, A S Planting, R Oosterom, et al.
British Journal of Cancer|November 21, 1998
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patientsR de Wit, W H Kruit, G Stoter, et al.
Emerging Infectious Diseases|October 19, 2005
Cyclosporiasis outbreak, IndonesiaMarjolijn C A Blans, Ben U Ridwan, Jaco J Verweij, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 4, 1994
[Strongyloides infections in former prisoners of war in South-East Asia in the second World War; additional information from serological diagnosis]A M Polderman, J J Verweij, J C Vetter, et al.
Pageof 66